Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 67557-1-Ig - Provider product page
- Provider
- Proteintech Group
- Product name
- USP15 antibody
- Antibody type
- Monoclonal
- Description
- USP15 antibody (Cat. #67557-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human, Mouse, Rat and has been validated for the following applications: IHC, WB, ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1C9G3
- Vial size
- 20ul, 150ul
Submitted references USP15 promotes the progression of papillary thyroid cancer by regulating HMGB1 stability through its deubiquitination.
Proteostatic reactivation of the developmental transcription factor TBX3 drives BRAF/MAPK-mediated tumorigenesis.
Long non-coding RNA MFSD4A-AS1 promotes lymphangiogenesis and lymphatic metastasis of papillary thyroid cancer.
The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression.
Wang SS, Ye DX, Wang B, Li MY, Zhao WX
Journal of Cancer 2024;15(9):2561-2572
Journal of Cancer 2024;15(9):2561-2572
Proteostatic reactivation of the developmental transcription factor TBX3 drives BRAF/MAPK-mediated tumorigenesis.
Zhang Z, Wu Y, Fu J, Yu X, Su Y, Jia S, Cheng H, Shen Y, He X, Ren K, Zheng X, Guan H, Rao F, Zhao L
Nature communications 2024 May 15;15(1):4108
Nature communications 2024 May 15;15(1):4108
Long non-coding RNA MFSD4A-AS1 promotes lymphangiogenesis and lymphatic metastasis of papillary thyroid cancer.
Liu X, Zhang C, Wang X, Cui C, Cui H, Zhu B, Chen A, Zhang L, Xin J, Fu Q, Dionigi G, Sun H
Endocrine-related cancer 2023 Mar 1;30(3)
Endocrine-related cancer 2023 Mar 1;30(3)
The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression.
Xia X, Huang C, Liao Y, Liu Y, He J, Shao Z, Hu T, Yu C, Jiang L, Liu J, Huang H
Cell death & disease 2021 Mar 26;12(4):329
Cell death & disease 2021 Mar 26;12(4):329
No comments: Submit comment
No validations: Submit validation data